The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of erlotinib for EGFR mutant NSCLC to prospectively assess biopsy feasibility and acquired resistance at disease progression.
 
Amanda J. Redig
No Relationships to Disclose
 
Myriam Taibi
No Relationships to Disclose
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Genentech; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - Patent pending
 
David Boucher
No Relationships to Disclose
 
Michael S. Rabin
No Relationships to Disclose
 
J Paul Marcoux
No Relationships to Disclose
 
Leena Gandhi
Honoraria - Merck
Consulting or Advisory Role - Genentech/Roche; Merck
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Mark Huberman
No Relationships to Disclose
 
Deepa Rangachari
No Relationships to Disclose
 
Joan Vern Lucca
No Relationships to Disclose
 
Linda K. Morse
No Relationships to Disclose
 
MaChristine Andan
Honoraria - Boehringer Ingelheim; Clovis Oncology
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology
Travel, Accommodations, Expenses - Boehringer Ingelheim; Clovis Oncology
 
Bruce E. Johnson
Stock and Other Ownership Interests - KEW
Honoraria - Chugai Pharma; Merck
Consulting or Advisory Role - ARIAD; AstraZeneca; Biothera; Bristol-Myers Squibb; Clovis Oncology; Dana-Farber Cancer Institute; GE Healthcare; KEW; Merck; Novartis; Otsuka; Puma Biotechnology; Synta; Teva; Transgene
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
Expert Testimony - Genentech
 
Daniel Botelho Costa
Honoraria - Boehringer Ingelheim; Pfizer
 
Pasi A. Janne
Stock and Other Ownership Interests - GATEKEEPER Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Clovis Oncology; Genentech; Merrimack; Pfizer; Roche Pharma AG; Sanofi
Other Relationship - LabCorp
 
David Michael Jackman
Consulting or Advisory Role - Genentech